# Chemoradiation or Brachytherapy for Rectal Cancer

> **NCT02017704** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 9 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **RADIATION:** Endo-HDR (if randomized to this arm)
- **DRUG:** capecitabine and IMRT (if randomized to this arm)
- **RADIATION:** IMRT (intensity modulated radiation therapy)
- **DRUG:** FOLFOX6
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02017704
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-12
- **Primary completion:** 2021-09-30
- **Final completion:** 2023-01-31
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017704, "Chemoradiation or Brachytherapy for Rectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02017704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*